Stay updated on Nintedanib IPF Trial: Twice Daily vs Placebo
Sign up to get notified when there's something new on the Nintedanib IPF Trial: Twice Daily vs Placebo page.

Latest updates to the Nintedanib IPF Trial: Twice Daily vs Placebo page
- Check3 days agoChange DetectedRevision: v3.3.4 updated in the page footer, replacing v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedThe page’s Locations section is expanded with numerous US and Canadian sites, and the revision marker updated to v3.3.3.SummaryDifference2%

- Check54 days agoChange DetectedPublications text updated to clarify auto-fill from PubMed; revision updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check61 days agoChange DetectedThe notice about government funding and operating status was removed from the page; this does not affect the study content or results, and core trial information remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check83 days agoChange DetectedNo significant changes were detected between the two screenshots. The study details and sections remain the same, with only minor UI/formatting differences if any.SummaryDifference0.3%

- Check104 days agoChange DetectedSignificant update: new operating-status notice and version bump to v3.2.0; previous v3.1.0 tag removed. Core content impacted by the new status information.SummaryDifference3%

Stay in the know with updates to Nintedanib IPF Trial: Twice Daily vs Placebo
Enter your email address, and we'll notify you when there's something new on the Nintedanib IPF Trial: Twice Daily vs Placebo page.